The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
How do patterns of progression influence treatment selection after chemohormonal therapy in patients with metastatic hormone sensitive prostate cancer?
 
Carlos Aguado De La Rosa
Travel, Accommodations, Expenses - GlaxoSmithKline; Pfizer
 
Iciar Garcia Carbonero
No Relationships to Disclose
 
Guillermo De Velasco
No Relationships to Disclose
 
Teresa Alonso
No Relationships to Disclose
 
Maria L. Villalobos
No Relationships to Disclose
 
Maria Garrido
No Relationships to Disclose
 
Isabel Gallegos
No Relationships to Disclose
 
Almudena Martin
No Relationships to Disclose
 
Alvaro Pinto
No Relationships to Disclose
 
Constanza Maximiano Alonso
No Relationships to Disclose
 
Jf Rodriguez-Moreno
No Relationships to Disclose
 
Laura Rodriguez
No Relationships to Disclose
 
Maria Sereno
No Relationships to Disclose
 
Carmen Perezagua
No Relationships to Disclose
 
David Marrupe
No Relationships to Disclose
 
Alejandro Riquelme
No Relationships to Disclose
 
Javier Cassinello
Consulting or Advisory Role - Astellas Oncology; Janssen; Sanofi
 
Enrique Grande
No Relationships to Disclose
 
Javier Puente
Consulting or Advisory Role - Janssen; Lilly; Pfizer; Roche
Speakers' Bureau - Astellas Oncology; Boehringer Ingelheim; Pfizer
Research Funding - Astellas Oncology (Inst); Pfizer (Inst)
 
Pablo Gajate
No Relationships to Disclose